137 related articles for article (PubMed ID: 37326033)
1. Artesunate synergistically promotes sorafenib‑induced apoptosis and ferroptosis in non‑Hodgkin lymphoma cells through inhibition of the STAT3 pathway.
Chen Y; Tao H; Wang F; Wu P; Gao J; Zhang X; He Z; Zhou Z; Jia Y
Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37326033
[TBL] [Abstract][Full Text] [Related]
2. Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling.
Chen Y; Wang F; Wu P; Gong S; Gao J; Tao H; Shen Q; Wang S; Zhou Z; Jia Y
Cell Signal; 2021 Dec; 88():110167. PubMed ID: 34628002
[TBL] [Abstract][Full Text] [Related]
3. Iron chelator deferasirox inhibits NF-κB activity in hepatoma cells and changes sorafenib-induced programmed cell deaths.
Jomen W; Ohtake T; Akita T; Suto D; Yagi H; Osawa Y; Kohgo Y
Biomed Pharmacother; 2022 Sep; 153():113363. PubMed ID: 35834989
[TBL] [Abstract][Full Text] [Related]
4. Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma.
Jing W; Shuo L; Yingru X; Min M; Runpeng Z; Jun X; Dong H
Biochem Biophys Res Commun; 2019 Oct; 519(1):41-45. PubMed ID: 31481232
[TBL] [Abstract][Full Text] [Related]
5. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma.
Li ZJ; Dai HQ; Huang XW; Feng J; Deng JH; Wang ZX; Yang XM; Liu YJ; Wu Y; Chen PH; Shi H; Wang JG; Zhou J; Lu GD
Acta Pharmacol Sin; 2021 Feb; 42(2):301-310. PubMed ID: 32699265
[TBL] [Abstract][Full Text] [Related]
6. Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway.
Kong Z; Liu R; Cheng Y
Biomed Pharmacother; 2019 Jan; 109():2043-2053. PubMed ID: 30551460
[TBL] [Abstract][Full Text] [Related]
7. Phosphorescent rhenium(I) complexes conjugated with artesunate: Mitochondrial targeting and apoptosis-ferroptosis dual induction.
Ye RR; Chen BC; Lu JJ; Ma XR; Li RT
J Inorg Biochem; 2021 Oct; 223():111537. PubMed ID: 34273716
[TBL] [Abstract][Full Text] [Related]
8. Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells.
Song Q; Peng S; Che F; Zhu X
J Pharmacol Sci; 2022 Mar; 148(3):300-306. PubMed ID: 35177209
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib and CuB exert synergistic antitumor effects against hepatocellular carcinoma cells via inhibition of STAT3 phosphorylation.
Wang X; Li H; Li D; Bai Y; Zhang Y; Yan X; Li J; Zhao R; Liu J; Liu W; Shi M; Xu C; Yang T; Zhang T
FEBS Open Bio; 2021 Jan; 11(1):133-145. PubMed ID: 33176070
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Eur J Pharmacol; 2020 Apr; 872():172953. PubMed ID: 31996318
[TBL] [Abstract][Full Text] [Related]
11. Ascorbic acid induces ferroptosis via STAT3/GPX4 signaling in oropharyngeal cancer.
Wu K; Liu L; Wu Z; Huang Q; Zhou L; Xie R; Wang M
Free Radic Res; 2024 Feb; 58(2):117-129. PubMed ID: 38385781
[TBL] [Abstract][Full Text] [Related]
12. Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma.
Saraswati S; Alhaider A; Abdelgadir AM; Tanwer P; Korashy HM
Cell Commun Signal; 2019 Oct; 17(1):127. PubMed ID: 31619257
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis inhibitor ferrostatin‑1 alleviates homocysteine‑induced ovarian granulosa cell injury by regulating TET activity and DNA methylation.
Shi Q; Liu R; Chen L
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169856
[TBL] [Abstract][Full Text] [Related]
14. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
Huang CY; Chen LJ; Chen G; Chao TI; Wang CY
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407
[TBL] [Abstract][Full Text] [Related]
15. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
16. Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3/GPX4 signalling.
Zhang W; Gong M; Zhang W; Mo J; Zhang S; Zhu Z; Wang X; Zhang B; Qian W; Wu Z; Ma Q; Wang Z
Cell Death Dis; 2022 Jul; 13(7):630. PubMed ID: 35859150
[TBL] [Abstract][Full Text] [Related]
17. High‑throughput screening identification of a small‑molecule compound that induces ferroptosis and attenuates the invasion and migration of hepatocellular carcinoma cells by targeting the STAT3/GPX4 axis.
Huang Q; Li J; Ma M; Lv M; Hu R; Sun J; Zhong X; Sun X; Feng W; Ma W; Zhang W; Zhan B; Han Z; Zhou X
Int J Oncol; 2023 Mar; 62(3):. PubMed ID: 36825585
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells.
Yao X; Zhao CR; Yin H; Wang K; Gao JJ
Acta Pharmacol Sin; 2020 Dec; 41(12):1609-1620. PubMed ID: 32300243
[TBL] [Abstract][Full Text] [Related]
19. Artesunate induces ferroptosis by inhibiting the nuclear localization of SREBP2 in myeloma cells.
Liang L; Liu Y; Wu X; Chen Y
Int J Med Sci; 2023; 20(12):1535-1550. PubMed ID: 37859702
[No Abstract] [Full Text] [Related]
20. Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis.
Li Y; Xia J; Shao F; Zhou Y; Yu J; Wu H; Du J; Ren X
Biochem Biophys Res Commun; 2021 Jan; 534():877-884. PubMed ID: 33162029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
